Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2008 040 792.6 |
96 | EP file number | EAKZ | 08 77 9619.9 |
86 | WO file number | WAKZ | PCT/US2008/006156 |
97 | EP publication number | EPN | 2068927 |
87 | WO publication number | WPN | 2008143878 |
54 | Designation/title | TI | VERFAHREN ZUR REDUZIERUNG EOSINOPHILER SPIEGEL |
51 | IPC main class | ICM (ICMV) | A61K 39/395 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | C07K 16/28 (2006.01) |
22 | DE application date | DAT | May 14, 2008 |
96 | EP application date | EAT | May 14, 2008 |
86 | WO application date | WAT | May 14, 2008 |
43 | Date of first publication | OT | Nov 27, 2008 |
| Date of publication of grant | PET | Oct 21, 2015 |
71/73 | Applicant/owner | INH | AstraZeneca AB, 15185 Södertälje, SE; Kyowa Kirin Co., Ltd., Tokyo, JP |
72 | Inventor | IN | KOIKE, Masamichi, West Windsor, NJ 08550, US; SPITALNY, George, L., Yardley, PA 19067, US; WHEELER, Alistair, Northborough, MA 01532, US; WHITE, Barbara, Finksburg, MD 21048, US |
| Address for service | | RWS Group, Translation Division, CHALFONT ST PETER, Bucks SL9 9FG, GB |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 924422 P May 14, 2007
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 924832 P Jun 1, 2007
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 64612 Mar 14, 2008
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 935005 P Jul 20, 2007
|
| Due date | FT FG | May 31, 2026 Annual fee for the 19th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR |
81 | Designated WO countries | WDS | AL, RS, BA, MK |
| Published EP/WO documents | EPWOPN | Original document:
EP000002068927 Searchable text:
EP000002068927 Original document:
EP000002068927B1 Searchable text:
EP000002068927B1 Original document:
WO002008143878 Searchable text:
WO002008143878 |
43 | Date of first publication | EVT | Nov 27, 2008 |
| Date of the first transfer into DPMAregister | EREGT | May 27, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | May 6, 2025 (Show all update days)(Hide all update days)- May 6, 2025
- Due date: changed
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 21.10.2015: new
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 21.10.2015: deleted
- Jun 9, 2024; Mar 26, 2024; Mar 25, 2023; Jul 30, 2022; Mar 26, 2022; Apr 24, 2021; May 4, 2020; Jan 9, 2020; Dec 4, 2019; Aug 14, 2019; Jul 20, 2019; Jul 9, 2019; May 11, 2019; Oct 24, 2018; May 17, 2018; Jan 11, 2018; Dec 1, 2017; Nov 30, 2017; May 27, 2017; Nov 3, 2016; Sep 29, 2016; Jun 16, 2016; Jan 23, 2016; Nov 26, 2015; Oct 24, 2015; Oct 22, 2015; Feb 12, 2013; Jun 8, 2011
- Historical data not available for this/these date(s)
- May 27, 2011
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 10)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Nov 30, 2017 |
| Issue number | HN | 2 |
| Year | PJ | 2018 |
| Publication date | VT | Jan 11, 2018 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | AstraZeneca AB, Södertälje, SE; Biowa, Inc., Princeton, N.J., US |
71/73 | Previous applicant/owner | INHF | Biowa, Inc., Princeton, N.J., US, MedImmune, LLC, Gaithersburg, Md., US |